Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer

This publication has 54 references indexed in Scilit:

• Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
  International Journal of Cancer, 2013
• Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2
  Journal of Biological Chemistry, 2012
• Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
  Expert Opinion on Therapeutic Targets, 2012
• Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway
  Biomedicine & Pharmacotherapy, 2011
• Keratins in health and cancer: more than mere epithelial cell markers
  Oncogene, 2010
• The GIST paradigm: lessons for other kinase‐driven cancers
  The Journal of Pathology, 2010
• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
  The Lancet, 2010
• Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
  Annals of Oncology, 2007
• PI3K/Akt signalling pathway and cancer
  Cancer Treatment Reviews, 2004
• Gene Structure and Chromosome Localization to 7q21.3 of the Human Rod Photoreceptor Transducin γ-Subunit Gene (GNGT1)
  Genomics, 1996